Kaurenoic acid activates TGF-β signaling

Area of Science:

• Pharmacology
• Molecular Biology
• Cell Biology

Background:

• Kaurenoic acid (KA), derived from Aralia continentalis, is traditionally used for rheumatism.
• Previous research indicated KA suppresses inflammation via Nrf2 activation.
• The anti-inflammatory mechanisms of KA, particularly its interaction with TGF-β signaling, remain underexplored.

Purpose of the Study:

• To investigate the hypothesis that kaurenoic acid suppresses inflammatory responses by activating the transforming growth factor-beta (TGF-β) signaling pathway.
• To elucidate the specific molecular mechanisms by which KA influences TGF-β signaling.

Main Methods:

• Treatment of murine macrophage RAW 264.7, human lung epithelial cell MRC-5, and TGFβRII-defective HCT116 cells with KA.
• Intratracheal administration of KA to mouse lungs.
• Analysis of phosphorylated Smad2/Smad3 via western blot, TGFβ-dependent gene expression using α-SMA immunoblotting, and luciferase reporter assays.

Main Results:

• KA induced phosphorylation of Smad2 and Smad3, indicating activation of TGF-β signaling.
• Inhibition of TGF-β receptor I (TGFβR1) by EW7197 blocked KA-mediated Smad2 phosphorylation.
• KA treatment increased Smad-binding element transcriptional activity and induced α-smooth muscle actin (α-SMA) expression in vitro and in vivo.

Conclusions:

• Kaurenoic acid demonstrably activates the TGF-β signaling pathway.
• The findings suggest a strong association between TGF-β signaling activation and the anti-inflammatory effects of kaurenoic acid.